We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
-4.57%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$12.2B
AUM Growth
-$499M
Cap. Flow
-$541M
Cap. Flow %
-4.43%
Top 10 Hldgs %
52.02%
Holding
832
New
248
Increased
200
Reduced
214
Closed
170

Sector Composition

Rank Sector Weight
1 Energy 71.16%
2 Materials 2.11%
3 Consumer Discretionary 1.46%
4 Healthcare 1.42%
5 Industrials 1.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANAC
176
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$1.24M 0.01%
+21,342
New +$906K
NG icon
177
NovaGold Resources
NG
$2.6B
$1.17M 0.01%
396,514
+58,855
+17% +$206K
DYAX
178
DELISTED
DYAX CORPORATION
DYAX
$1.14M 0.01%
+67,807
New +$1.06M
TSRO
179
DELISTED
TESARO, Inc.
TSRO
$1.11M 0.01%
+19,325
New +$911K
DLR icon
180
Digital Realty Trust
DLR
$73.7B
$1.1M 0.01%
16,700
-122
-0.7% -$8.37K
UDR icon
181
UDR
UDR
$12.9B
$1.08M 0.01%
31,666
+703
+2% +$23.1K
IAG icon
182
IAMGOLD
IAG
$8.47B
$1.07M 0.01%
574,872
+152,057
+36% +$374K
RARE icon
183
Ultragenyx Pharmaceutical
RARE
$2.65B
$1.07M 0.01%
+17,304
New +$961K
PDLI
184
DELISTED
PDL BioPharma, Inc.
PDLI
$1.07M 0.01%
152,625
+86,043
+129% +$623K
MNKD icon
185
MannKind Corp
MNKD
$1.28B
$1.05M 0.01%
40,369
+38,105
+1,683% +$1.15M
PTCT icon
186
PTC Therapeutics
PTCT
$6.37B
$1.02M 0.01%
+16,768
New +$1.02M
PTLA
187
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$918K 0.01%
+24,195
New +$831K
MDCO
188
DELISTED
Medicines Co
MDCO
$911K 0.01%
+32,526
New +$914K
INVA icon
189
Innoviva
INVA
$1.58B
$908K 0.01%
+57,752
New +$874K
HALO icon
190
Halozyme
HALO
$9.72B
$890K 0.01%
+62,310
New +$898K
ARE icon
191
Alexandria Real Estate Equities
ARE
$8.88B
$878K 0.01%
8,960
+201
+2% +$19.4K
CPT icon
192
Camden Property Trust
CPT
$11.3B
$829K 0.01%
10,614
+40
+0.4% +$3.07K
MOS icon
193
The Mosaic Company
MOS
$7.09B
$807K 0.01%
17,511
-3,973
-18% -$194K
SCMP
194
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$807K 0.01%
+51,888
New +$804K
HAL icon
195
Halliburton
HAL
$27.9B
$793K 0.01%
18,062
+3,794
+27% +$158K
KRC icon
196
Kilroy Realty
KRC
$4.58B
$793K 0.01%
10,410
+233
+2% +$17.4K
REG icon
197
Regency Centers
REG
$15B
$789K 0.01%
11,597
+259
+2% +$17.4K
ISEE
198
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$776K 0.01%
+16,684
New +$866K
VLO icon
199
Valero Energy
VLO
$89.8B
$767K 0.01%
12,049
-2,927
-20% -$163K
ENTA icon
200
Enanta Pharmaceuticals
ENTA
$372M
$746K 0.01%
24,379
+10,805
+80% +$420K

Similar funds

ALPS Advisors's Q1 2015 Portfolio in Review

As of Q1 2015, ALPS Advisors held 832 positions worth $12.2B, down 3.9% from $12.7B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

ALPS Advisors withdrew a net $541M in Q1 2015, closing 170 positions and reducing 214 holdings. Its most notable exit was WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT, an estimated $434M position sold in full.

By sector, the portfolio is most concentrated in Energy at 71% of assets, down from 73% a quarter earlier, followed by Materials and Consumer Discretionary.

Against the trend, ALPS Advisors opened a new position in iShares Core S&P 500 ETF worth $191M.

  • ALPS Advisors's largest Q1 2015 buy was iShares Core S&P 500 ETF: 920,757 shares worth $191M.
  • ALPS Advisors added most to Williams Partners L.P. in Q1 2015, an estimated $362M increase.
  • ALPS Advisors's biggest Q1 2015 reduction was Lumen, cutting an estimated $406M.
  • ALPS Advisors fully exited WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT in Q1 2015, selling an estimated $434M.
  • ALPS Advisors's ten largest holdings make up 52% of its $12.2B portfolio in Q1 2015.
  • ALPS Advisors opened 248 new positions and closed 170 in Q1 2015.
  • ALPS Advisors's portfolio value fell 3.9% quarter-over-quarter to $12.2B.

Based on ALPS Advisors's 13F filing for Q1 2015, filed 15 May 2015.